FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Margaret Shipp

Research Profile

Disorders

Chemicals & Drugs

Procedures

Physiology

Concepts & Ideas

Molecular Sequence Data

Anatomy

Living Beings

Mouse

Co-author Network

Publications

TOP 3
Jing Ouyang; Annette Plütschow; Sabine Ponader; Gabriel A Rabinovich; Katrin S Reiners; Andreas Engert; Donna Neuberg; Elke Pogge Von Strandmann; Margaret A Shipp
Galectin-1 serum levels reflect tumor burden and adverse clinical features in classical Hodgkin lymphoma.
Qingsheng Yan; Liya Zhu; Xin Cheng; John Manis; Zhe Wang; Rong Xu; Margaret A Shipp
BAL1 and its partner E3 ligase, BBAP, link Poly(ADP-ribose) activation, ubiquitylation, and double-strand DNA repair independent of ATM, MDC1, and RNF8.
Pilar Caro; Bjoern Chapuy; Linfeng Chen; Scott B Ficarro; John Gounarides; Michael Green; Amar U Kishan; Jarrod A Marto; Stefano Monti; Erik Norberg; Klaudia Polak; Margaret A Shipp; Illana A Stanley; Daniel Tondera; Hong Yin; Feng Zhou; Nika N Danial
Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Margaret Shipp (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jing Ouyang; Annette Plütschow; Sabine Ponader; Gabriel A Rabinovich; Katrin S Reiners; Andreas Engert; Donna Neuberg; Elke Pogge Von Strandmann; Margaret A Shipp
Galectin-1 serum levels reflect tumor burden and adverse clinical features in classical Hodgkin lymphoma.
Blood 2013;121(17):3431-3.
2013: Qingsheng Yan; Liya Zhu; Xin Cheng; John Manis; Zhe Wang; Rong Xu; Margaret A Shipp
BAL1 and its partner E3 ligase, BBAP, link Poly(ADP-ribose) activation, ubiquitylation, and double-strand DNA repair independent of ATM, MDC1, and RNF8.
Molecular and cellular biology 2013;33(4):845-57.
2012: Pilar Caro; Bjoern Chapuy; Linfeng Chen; Scott B Ficarro; John Gounarides; Michael Green; Amar U Kishan; Jarrod A Marto; Stefano Monti; Erik Norberg; Klaudia Polak; Margaret A Shipp; Illana A Stanley; Daniel Tondera; Hong Yin; Feng Zhou; Nika N Danial
Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma.
Cancer cell 2012;22(4):547-60.
2012: Stefano Monti; Donna Neuberg; Scott J Rodig; Kunihiko Takeyama; Kelly T Yeda; Rameen Beroukhim; Bjoern Chapuy; Treeve Currie; Ahmet Dogan; Gad Getz; Todd R Golub; Thomas M Habermann; Yansheng Hao; Haig Inguilizian; Andrew L Kung; Jeffery L Kutok; Craig Mermel; Margaret A Shipp
Integrative analysis reveals an outcome-associated and targetable pattern of p53 and cell cycle deregulation in diffuse large B cell lymphoma.
Cancer cell 2012;22(3):359-72.
2012: Michael Green; Przemyslaw Juszczynski; Donna Neuberg; Evan O'Donnell; Jing Ouyang; Scott J Rodig; Papiya Sinha; Margaret A Shipp
Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(6):1611-8.
2012: Michael J Kluk; Stefano Monti; Donna Neuberg; Geraldine S Pinkus; Bjoern Chapuy; Paola Dal Cin; Alyssa Roy; Margaret A Shipp; Papiya Sinha; Scott J Rodig
Immunohistochemical detection of MYC-driven diffuse large B-cell lymphomas.
PloS one 2012;7(4):e33813.
2011: Jing Ouyang; Przemyslaw Juszczynski; Scott J Rodig; Michael Green; Evan O'Donnell; Treeve Currie; Myriam Armant; Kunihiko Takeyama; Stefano Monti; Gabriel A Rabinovich; Jerome Ritz; Jeffery L Kutok; Margaret A Shipp
Viral induction and targeted inhibition of galectin-1 in EBV+ posttransplant lymphoproliferative disorders.
Blood 2011;117(16):4315-22.
2011: Michael Green; Stefano Monti; Riccardo Dalla-Favera; Laura Pasqualucci; Nicole C Walsh; Marc Schmidt-Supprian; Jeffery L Kutok; Scott Rodig; Donna S Neuberg; Klaus Rajewsky; Todd R Golub; Frederick W Alt; Margaret A Shipp; John P Manis
Signatures of murine B-cell development implicate Yy1 as a regulator of the germinal center-specific program.
Proceedings of the National Academy of Sciences of the United States of America 2011;108(7):2873-8.
2010: Michael Green; Stefano Monti; Scott J Rodig; Przemyslaw Juszczynski; Treeve Currie; Evan O'Donnell; Bjoern Chapuy; Kunihiko Takeyama; Donna Neuberg; Todd R Golub; Jeffery L Kutok; Margaret A Shipp
Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.
Blood 2010;116(17):3268-77.
2010: Przemyslaw Juszczynski; Scott J Rodig; Jing Ouyang; Evan O'Donnell; Kunihiko Takeyama; Wojciech Mlynarski; Katarzyna Mycko; Tomasz Szczepanski; Anna Gaworczyk; Andrei Krivtsov; Joerg Faber; Amit U Sinha; Gabriel A Rabinovich; Scott A Armstrong; Jeffery L Kutok; Margaret A Shipp
MLL-rearranged B lymphoblastic leukemias selectively express the immunoregulatory carbohydrate-binding protein galectin-1.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(7):2122-30.
2010: Jonathan W Friedberg; Jeff Sharman; John Sweetenham; Patrick B Johnston; Julie M Vose; Ann S LaCasce; Julia Schaefer-Cutillo; Sven De Vos; Rajni Sinha; John P Leonard; Larry D Cripe; Stephanie A Gregory; Michael P Sterba; Ann M Lowe; Ronald Levy; Margaret A Shipp
Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia.
Blood 2010;115(13):2578-85.
2009: Przemyslaw Juszczynski; Linfeng Chen; Evan O'Donnell; Jose M Polo; Stella M Ranuncolo; Riccardo Dalla-Favera; Ari Melnick; Margaret A Shipp
BCL6 modulates tonic BCR signaling in diffuse large B-cell lymphomas by repressing the SYK phosphatase, PTPROt.
Blood 2009;114(26):5315-21.
2009: Qingsheng Yan; Shilpee Dutt; Rong Xu; Katherine Graves; Przemyslaw Juszczynski; John P Manis; Margaret A Shipp
BBAP monoubiquitylates histone H4 at lysine 91 and selectively modulates the DNA damage response.
Molecular cell 2009;36(1):110-20.
2009: Jeremy S Abramson; Wen Chen; Przemyslaw Juszczynski; Hidenobu Takahashi; Donna Neuberg; Jeffery L Kutok; Kunihiko Takeyama; Margaret A Shipp
The heat shock protein 90 inhibitor IPI-504 induces apoptosis of AKT-dependent diffuse large B-cell lymphomas.
British journal of haematology 2009;144(3):358-66.
2008: Scott J Rodig; Jing Ouyang; Przemyslaw Juszczynski; Treeve Currie; Kenneth Law; Donna Neuberg; Gabriel A Rabinovich; Margaret A Shipp; Jeffery L Kutok
AP1-dependent galectin-1 expression delineates classical hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(11):3338-44.
2008: Linfeng Chen; Stefano Monti; Przemyslaw Juszczynski; John Daley; Wen Chen; Thomas E Witzig; Thomas M Habermann; Jeffery L Kutok; Margaret A Shipp
SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma.
Blood 2008;111(4):2230-7.
2008: Kunihiko Takeyama; S Monti; John P Manis; P Dal Cin; Gad Getz; Rameen Beroukhim; Shilpee Dutt; Jon C Aster; Frederick W Alt; Todd R Golub; Margaret A Shipp
Integrative analysis reveals 53BP1 copy loss and decreased expression in a subset of human diffuse large B-cell lymphomas.
Oncogene 2008;27(3):318-22.
2007: Samir Parekh; Jose M Polo; Rita Shaknovich; Przemyslaw Juszczynski; Paola Lev; Stella Maris Ranuncolo; Yingnan Yin; Ulf Klein; Giorgio Cattoretti; Riccardo Dalla-Favera; Margaret A Shipp; Ari Melnick
BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms.
Blood 2007;110(6):2067-74.
2007: Przemyslaw Juszczynski; Jing Ouyang; Stefano Monti; Scott J Rodig; Kunihiko Takeyama; Jeremy Abramson; Wen Chen; Jeffery L Kutok; Gabriel A Rabinovich; Margaret A Shipp
The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(32):13134-9.
2007: Jing Deng; Nicole Carlson; Kunihiko Takeyama; Paola Dal Cin; Margaret A Shipp; Anthony Letai
BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents.
Cancer cell 2007;12(2):171-85.
2007: Bruce A Peterson; Jeffrey Johnson; Margaret A Shipp; Maurice Barcos; Jon P Gockerman; George P Canellos
High dose CHOP: a phase II study of initial treatment in aggressive non-Hodgkin lymphoma. Cancer and Leukemia Group B 9351.
Leukemia & lymphoma 2007;48(5):870-80.
2007: Michael J Robertson; Brad S Kahl; Julie M Vose; Sven de Vos; Mary Laughlin; Patrick J Flynn; Kendrith M Rowland; Jose C Cruz; Stuart L Goldberg; Luna Musib; Christelle Darstein; Nathan Enas; Jeffery L Kutok; Jon C Aster; Donna Neuberg; Kerry J Savage; Ann S LaCasce; Donald Thornton; Christopher A Slapak; Margaret A Shipp
Phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory diffuse large B-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(13):1741-6.
2007: Jose M Polo; Przemyslaw Juszczynski; Stefano Monti; Leandro C A Cerchietti; Qian Ye; John M Greally; Margaret A Shipp; Ari Melnick
Transcriptional signature with differential expression of BCL6 target genes accurately identifies BCL6-dependent diffuse large B cell lymphomas.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(9):3207-12.
2007: Margaret A Shipp
Molecular signatures define new rational treatment targets in large B-cell lymphomas.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2007;():265-9.
2007: Scott J Rodig; Kerry J Savage; Ann S LaCasce; Andrew P Weng; Nancy Lee Harris; Margaret A Shipp; Eric D Hsi; Randy D Gascoyne; Jeffery L Kutok
Expression of TRAF1 and nuclear c-Rel distinguishes primary mediastinal large cell lymphoma from other types of diffuse large B-cell lymphoma.
The American journal of surgical pathology 2007;31(1):106-12.
2006: Scott J Rodig; Jeremy S Abramson; Geraldine S Pinkus; Steve P Treon; David M Dorfman; Henry Y Dong; Margaret A Shipp; Jeffery L Kutok
Heterogeneous CD52 expression among hematologic neoplasms: implications for the use of alemtuzumab (CAMPATH-1H).
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(23):7174-9.
2006: Linfeng Chen; Przemyslaw Juszczynski; Kunihiko Takeyama; Ricardo Aguiar; Margaret A Shipp
Protein tyrosine phosphatase receptor-type O truncated (PTPROt) regulates SYK phosphorylation, proximal B-cell-receptor signaling, and cellular proliferation.
Blood 2006;108(10):3428-33.
2006: Przemyslaw Juszczynski; Jeffery L Kutok; Cheng Li; Joydeep Mitra; Ricardo Aguiar; Margaret A Shipp
BAL1 and BBAP are regulated by a gamma interferon-responsive bidirectional promoter and are overexpressed in diffuse large B-cell lymphomas with a prominent inflammatory infiltrate.
Molecular and cellular biology 2006;26(14):5348-59.
2006: Hidenobu Takahashi; Friedrich Feuerhake; Jeffery L Kutok; Stefano Monti; Paola Dal Cin; Donna Neuberg; Jon C Aster; Margaret A Shipp
FAS death domain deletions and cellular FADD-like interleukin 1beta converting enzyme inhibitory protein (long) overexpression: alternative mechanisms for deregulating the extrinsic apoptotic pathway in diffuse large B-cell lymphoma subtypes.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(11 Pt 1):3265-71.
2006: Laura Pasqualucci; Mara Compagno; Jane Houldsworth; Stefano Monti; Adina Grunn; Subhadra V Nandula; Jon C Aster; Vundavalli Murty; Margaret A Shipp; Riccardo Dalla-Favera
Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma.
The Journal of experimental medicine 2006;203(2):311-7.
2006: Margaret A Shipp
New concepts in treatment approaches and prognostic factors in aggressive NHL.
Clinical advances in hematology & oncology : H&O 2006;4(2):107-9.
2006: Hidenobu Takahashi; Friedrich Feuerhake; Stefano Monti; Jeffery L Kutok; Jon C Aster; Margaret A Shipp
Lack of IKBA coding region mutations in primary mediastinal large B-cell lymphoma and the host response subtype of diffuse large B-cell lymphoma.
Blood 2006;107(2):844-5.
2005: Ricardo Aguiar; Kunihiko Takeyama; Chunyan He; Katherine Kreinbrink; Margaret A Shipp
B-aggressive lymphoma family proteins have unique domains that modulate transcription and exhibit poly(ADP-ribose) polymerase activity.
The Journal of biological chemistry 2005;280(40):33756-65.
2005: Friedrich Feuerhake; Jeffery L Kutok; Stefano Monti; Wen Chen; Ann S LaCasce; Giorgio Cattoretti; Paul Kurtin; Geraldine S Pinkus; Laurence de Leval; Nancy Lee Harris; Kerry J Savage; Donna Neuberg; Thomas M Habermann; Riccardo Dalla-Favera; Todd R Golub; Jon C Aster; Margaret A Shipp
NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes.
Blood 2005;106(4):1392-9.
2005: Jeremy S Abramson; Margaret A Shipp
Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approach.
Blood 2005;106(4):1164-74.
2005: John R Goffin; Ian C Anderson; Jeffrey G Supko; Joseph P Eder; Geoffrey I Shapiro; Thomas J Lynch; Margaret A Shipp; Bruce E Johnson; Arthur T Skarin
Phase I trial of the matrix metalloproteinase inhibitor marimastat combined with carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(9):3417-24.
2005: Margaret A Shipp; Suzanne L Aquino; Nancy Lee Harris
Case records of the Massachusetts General Hospital. Case 12-2005. A 30-year-old woman with a mediastinal mass.
The New England journal of medicine 2005;352(16):1697-704.
2005: Stefano Monti; Kerry J Savage; Jeffery L Kutok; Friedrich Feuerhake; Paul Kurtin; Martin Mihm; Bingyan Wu; Laura Pasqualucci; Donna Neuberg; Ricardo Aguiar; Paola Dal Cin; Christine Ladd; Geraldine S Pinkus; Gilles SALLES; Nancy Lee Harris; Riccardo Dalla-Favera; Thomas M Habermann; Jon C Aster; Todd R Golub; Margaret A Shipp
Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response.
Blood 2005;105(5):1851-61.
2005: Scott J Rodig; Kerry J Savage; Vuong Nguyen; Geraldine S Pinkus; Margaret A Shipp; Jon C Aster; Jeffery L Kutok
TRAF1 expression and c-Rel activation are useful adjuncts in distinguishing classical Hodgkin lymphoma from a subset of morphologically or immunophenotypically similar lymphomas.
The American journal of surgical pathology 2005;29(2):196-203.
2005: Krystel Louis; Nathalie C Guérineau; Olivia Fromigué; Virginie Defamie; Alejandra Collazos; Patrick Anglard; Margaret A Shipp; Patrick Auberger; Dominique Joubert; Bernard Mari
Tumor cell-mediated induction of the stromal factor stromelysin-3 requires heterotypic cell contact-dependent activation of specific protein kinase C isoforms.
The Journal of biological chemistry 2005;280(2):1272-83.
2005: Peter G Smith; Fengfei Wang; Kathryn N Wilkinson; Kerry J Savage; Ulf Klein; Donna Neuberg; Gideon Bollag; Margaret A Shipp; Ricardo Aguiar
The phosphodiesterase PDE4B limits cAMP-associated PI3K/AKT-dependent apoptosis in diffuse large B-cell lymphoma.
Blood 2005;105(1):308-16.
2004: Ann S LaCasce; Orion M Howard; S Lib; David C Fisher; Andrew P Weng; Donna Neuberg; Margaret A Shipp
Modified magrath regimens for adults with Burkitt and Burkitt-like lymphomas: preserved efficacy with decreased toxicity.
Leukemia & lymphoma 2004;45(4):761-7.
2003: Kerry J Savage; Stefano Monti; Jeffery L Kutok; Giorgio Cattoretti; Donna Neuberg; Laurence De Leval; Paul Kurtin; Paola Dal Cin; Christine Ladd; Friedrich Feuerhake; Ricardo Aguiar; Sigui Li; Gilles SALLES; Francoise Berger; Wen Jing; Geraldine S Pinkus; Thomas M Habermann; Riccardo Dalla-Favera; Nancy Lee Harris; Jon C Aster; Todd R Golub; Margaret A Shipp
The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.
Blood 2003;102(12):3871-9.
2003: Kathryn Wilkinson; Elvira R P Velloso; Luiz Fernando Lopes; Charles Lee; Jon C Aster; Margaret A Shipp; Ricardo Aguiar
Cloning of the t(1;5)(q23;q33) in a myeloproliferative disorder associated with eosinophilia: involvement of PDGFRB and response to imatinib.
Blood 2003;102(12):4187-90.
2003: Olivia Fromigué; Krystel Louis; Erxi Wu; Nathalie Belhacène; Agnès Loubat; Margaret A Shipp; Patrick Auberger; Bernard Mari
Active stromelysin-3 (MMP-11) increases MCF-7 survival in three-dimensional Matrigel culture via activation of p42/p44 MAP-kinase.
International journal of cancer. Journal international du cancer 2003;106(3):355-63.
2003: Kunihiko Takeyama; Ricardo Aguiar; Liqun Gu; Chunyan He; Gordon J Freeman; Jeffery L Kutok; Jon C Aster; Margaret A Shipp
The BAL-binding protein BBAP and related Deltex family members exhibit ubiquitin-protein isopeptide ligase activity.
The Journal of biological chemistry 2003;278(24):21930-7.
2003: Rita M Braziel; Margaret A Shipp; Andrew L Feldman; Virginia Espina; Mary Winters; Elaine S Jaffe; Emanuel F Petricoin; Lance A Liotta
Molecular diagnostics.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2003;():279-93.
2002: Thomas S Lin; Orion M Howard; Donna Neuberg; Helen H Kim; Margaret A Shipp
Seventy-two hour continuous infusion flavopiridol in relapsed and refractory mantle cell lymphoma.
Leukemia & lymphoma 2002;43(4):793-7.
2002: Orion M Howard; John G Gribben; Donna Neuberg; Michael L Grossbard; Christine M Poor; Milos J Janicek; Margaret A Shipp
Rituximab and CHOP induction therapy for newly diagnosed mantle-cell lymphoma: molecular complete responses are not predictive of progression-free survival.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(5):1288-94.
2002: Margaret A Shipp; Kenneth N Ross; Pablo Tamayo; Andrew P Weng; Jeffery L Kutok; Ricardo Aguiar; Michelle Gaasenbeek; Michael Angelo; Michael Reich; Geraldine S Pinkus; Tane S Ray; Margaret A Koval; Kim W Last; Andrew Norton; T Andrew Lister; Jill P Mesirov; Donna Neuberg; Eric S Lander; Jon C Aster; Todd R Golub
Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning.
Nature medicine 2002;8(1):68-74.
2001: Erxi Wu; Bernard Mari; F Wang; IC Anderson; M E Sunday; Margaret A Shipp
Stromelysin-3 suppresses tumor cell apoptosis in a murine model.
Journal of cellular biochemistry 2001;82(4):549-55.
2000: Ruoqian Shen; Makoto Sumitomo; Jie Dai; D O Hardy; Daniel Navarro; BA Usmani; CN Papandreou; Louis B Hersh; Margaret A Shipp; L P Freedman; David M Nanus
Identification and characterization of two androgen response regions in the human neutral endopeptidase gene.
Molecular and cellular endocrinology 2000;170(1-2):131-42.
2000: Ricardo Aguiar; Y Yakushijin; S Kharbanda; Ravi Salgia; J A Fletcher; Margaret A Shipp
BAL is a novel risk-related gene in diffuse large B-cell lymphomas that enhances cellular migration.
Blood 2000;96(13):4328-34.
2000: IC Anderson; S E Mari; Ryan Broderick; Bernard Mari; Margaret A Shipp
The angiogenic factor interleukin 8 is induced in non-small cell lung cancer/pulmonary fibroblast cocultures.
Cancer research 2000;60(2):269-72.
1999: Ricardo Aguiar; Y Yakushijin; S Kharbanda; Sanjay Tiwari; Gordon J Freeman; Margaret A Shipp
PTPROt: an alternatively spliced and developmentally regulated B-lymphoid phosphatase that promotes G0/G1 arrest.
Blood 1999;94(7):2403-13.
1999: Bruce D Cheson; Sandra J Horning; Bertrand Coiffier; Margaret A Shipp; Richard I Fisher; J M Connors; T A Lister; Julie M Vose; Antonio J Grillo-López; A Hagenbeek; F Cabanillas; D Klippensten; W Hiddemann; R Castellino; N L Harris; James O Armitage; W Carter; R Hoppe; George P Canellos
Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(4):1244.
1999: Margaret A Shipp; M D Abeloff; Karen Antman; G Carroll; A Hagenbeek; Markus Loeffler; E Montserrat; J A Radford; Gilles SALLES; Norbert Schmitz; M Symann; James O Armitage; T Philip; Bertrand Coiffier
International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: report of the jury.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(1):423-9.
1999: Margaret A Shipp; M D Abeloff; Karen Antman; G Carroll; A Hagenbeek; Markus Loeffler; E Montserrat; J A Radford; Gilles SALLES; Norbert Schmitz; M Symann; James O Armitage; Bertrand Coiffier; T Philip
International Consensus Conference on high-dose therapy with hematopoietic stem-cell transplantation in aggressive non-Hodgkin's lymphomas: report of the jury.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(1):13-9.
1998: Orion M Howard; Margaret A Shipp
The cellular and molecular heterogeneity of the aggressive non-Hodgkin's lymphomas.
Current opinion in oncology 1998;10(5):385-91.
1998: Y Yakushijin; J Steckel; S Kharbanda; R Hasserjian; Donna Neuberg; W Jiang; I Anderson; Margaret A Shipp
A directly spliced exon 10-containing CD44 variant promotes the metastasis and homotypic aggregation of aggressive non-Hodgkin's lymphoma.
Blood 1998;91(11):4282-91.
1998: Bernard Mari; IC Anderson; S E Mari; Y Ning; Y Lutz; L Kobzik; Margaret A Shipp
Stromelysin-3 is induced in tumor/stroma cocultures and inactivated via a tumor-specific and basic fibroblast growth factor-dependent mechanism.
The Journal of biological chemistry 1998;273(1):618-26.
1997: F Ishimaru; Bernard Mari; Margaret A Shipp
The type 2 CD10/neutral endopeptidase 24.11 promoter: functional characterization and tissue-specific regulation by CBF/NF-Y isoforms.
Blood 1997;89(11):4136-45.
1997: Milos J Janicek; W Kaplan; Donna Neuberg; George P Canellos; Larry N Shulman; Margaret A Shipp
Early restaging gallium scans predict outcome in poor-prognosis patients with aggressive non-Hodgkin's lymphoma treated with high-dose CHOP chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(4):1631-7.
1997: Margaret A Shipp
Can we improve upon the International Index?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8 Suppl 1():43-7.
1996: R K Ganju; R G Shpektor; D G Brenner; Margaret A Shipp
CD10/neutral endopeptidase 24.11 is phosphorylated by casein kinase II and coassociates with other phosphoproteins including the lyn src-related kinase.
Blood 1996;88(11):4159-65.
1996: F Ishimaru; N S Potter; Margaret A Shipp
Phorbol ester-mediated regulation of CD10/neutral endopeptidase transcripts in acute lymphoblastic leukemias.
Experimental hematology 1996;24(1):43-8.
1995: Margaret A Shipp; Donna Neuberg; M Janicek; George P Canellos; Larry N Shulman
High-dose CHOP as initial therapy for patients with poor-prognosis aggressive non-Hodgkin's lymphoma: a dose-finding pilot study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(12):2916-23.
1995: I C Anderson; D J Sugarbaker; R K Ganju; D G Tsarwhas; W G Richards; Mary E Sunday; L Kobzik; Margaret A Shipp
Stromelysin-3 is overexpressed by stromal elements in primary non-small cell lung cancers and regulated by retinoic acid in pulmonary fibroblasts.
Cancer research 1995;55(18):4120-6.
1995: Jeffrey M Drazen; J F Evans; R L Stevens; Margaret A Shipp
Inflammatory effector mechanisms in asthma.
American journal of respiratory and critical care medicine 1995;152(1):403-7.
1995: F Ishimaru; Margaret A Shipp
Analysis of the human CD10/neutral endopeptidase 24.11 promoter region: two separate regulatory elements.
Blood 1995;85(11):3199-207.
1994: R K Ganju; Mary E Sunday; D G Tsarwhas; A Card; Margaret A Shipp
CD10/NEP in non-small cell lung carcinomas. Relationship to cellular proliferation.
The Journal of clinical investigation 1994;94(5):1784-91.
1994: Margaret A Shipp
Prognostic factors in aggressive non-Hodgkin's lymphoma: who has "high-risk" disease?
Blood 1994;83(5):1165-73.
1994: Gilles SALLES; Margaret A Shipp; Bertrand Coiffier
Chemotherapy of non-Hodgkin's aggressive lymphomas.
Seminars in hematology 1994;31(1):46-69.
1993: G Salles; M Zain; W M Jiang; Vassiliki A Boussiotis; Margaret A Shipp
Alternatively spliced CD44 transcripts in diffuse large-cell lymphomas: characterization and comparison with normal activated B cells and epithelial malignancies.
Blood 1993;82(12):3539-47.
1993: Gilles SALLES; H R Rodewald; B S Chin; Ellis L Reinherz; Margaret A Shipp
Inhibition of CD10/neutral endopeptidase 24.11 promotes B-cell reconstitution and maturation in vivo.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(16):7618-22.
1993: Margaret A Shipp; A T Look
Hematopoietic differentiation antigens that are membrane-associated enzymes: cutting is the key!
Blood 1993;82(4):1052-70.
1993: D Kirn; Peter M Mauch; K Shaffer; Geraldine S Pinkus; Margaret A Shipp; W D Kaplan; N Tung; C Wheeler; Clair Beard; George P Canellos
Large-cell and immunoblastic lymphoma of the mediastinum: prognostic features and treatment outcome in 57 patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(7):1336-43.
1993: K A King; J Hua; John S Torday; Jeffrey M Drazen; SA Graham; Margaret A Shipp; Mary E Sunday
CD10/neutral endopeptidase 24.11 regulates fetal lung growth and maturation in utero by potentiating endogenous bombesin-like peptides.
The Journal of clinical investigation 1993;91(5):1969-73.
1992: W Heagy; Margaret A Shipp; Robert W Finberg
Opioid receptor agonists and Ca2+ modulation in human B cell lines.
Journal of immunology (Baltimore, Md. : 1950) 1992;149(12):4074-81.
1992: Mary E Sunday; J Hua; John S Torday; B Reyes; Margaret A Shipp
CD10/neutral endopeptidase 24.11 in developing human fetal lung. Patterns of expression and modulation of peptide-mediated proliferation.
The Journal of clinical investigation 1992;90(6):2517-25.
1992: Gilles SALLES; C Y Chen; Ellis L Reinherz; Margaret A Shipp
CD10/NEP is expressed on Thy-1low B220+ murine B-cell progenitors and functions to regulate stromal cell-dependent lymphopoiesis.
Blood 1992;80(8):2021-9.
1992: Margaret A Shipp
Prognostic factors in non-Hodgkin's lymphoma.
Current opinion in oncology 1992;4(5):856-62.
1992: C Y Chen; Gilles SALLES; Michael F Seldin; A E Kister; Ellis L Reinherz; Margaret A Shipp
Murine common acute lymphoblastic leukemia antigen (CD10 neutral endopeptidase 24.11). Molecular characterization, chromosomal localization, and modeling of the active site.
Journal of immunology (Baltimore, Md. : 1950) 1992;148(9):2817-25.
1991: Margaret A Shipp; G E Tarr; Chang-Yan Chen; S N Switzer; Louis B Hersh; H Stein; Mary E Sunday; Ellis L Reinherz
CD10/neutral endopeptidase 24.11 hydrolyzes bombesin-like peptides and regulates the growth of small cell carcinomas of the lung.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(23):10662-6.
1991: Margaret A Shipp; Wlaszczuk Tomasz; S N Switzer; James D Griffin; Ellis L Reinherz
CD10 (CALLA)/neutral endopeptidase 24.11 modulates inflammatory peptide-induced changes in neutrophil morphology, migration, and adhesion proteins and is itself regulated by neutrophil activation.
Blood 1991;78(7):1834-41.
1991: Charles L Shapiro; B Y Yeap; J Godleski; Maxine Jochelson; Margaret A Shipp; Arthur T Skarin; George P Canellos
Drug-related pulmonary toxicity in non-Hodgkin's lymphoma. Comparative results with three different treatment regimens.
Cancer 1991;68(4):699-705.
1991: Jane C Weeks; B Y Yeap; George P Canellos; Margaret A Shipp
Value of follow-up procedures in patients with large-cell lymphoma who achieve a complete remission.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(7):1196-203.
1991: Wlaszczuk Tomasz; Margaret A Shipp; B Scharrer
A possible immunoregulatory function for [Met]-enkephalin-Arg6-Phe7 involving human and invertebrate granulocytes.
Journal of neuroimmunology 1991;31(2):97-103.
1991: Bertrand Coiffier; Margaret A Shipp; F Cabanillas; D Crowther; J O Armitage; George P Canellos
Report of the first workshop on prognostic factors in large-cell lymphomas.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2 Suppl 2():213-7.
1990: Margaret A Shipp; Wlaszczuk Tomasz; Luciano D'Adamio; S N Switzer; F D Howard; J Sinisterra; B Scharrer; Ellis L Reinherz
Downregulation of enkephalin-mediated inflammatory responses by CD10/neutral endopeptidase 24.11.
Nature 1990;347(6291):394-6.
1990: Thomas K Hughes; Eric M Smith; R Chin; P Cadet; J Sinisterra; M K Leung; Margaret A Shipp; B Scharrer; Wlaszczuk Tomasz
Interaction of immunoactive monokines (interleukin 1 and tumor necrosis factor) in the bivalve mollusc Mytilus edulis.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(12):4426-9.
1990: Margaret A Shipp; B Y Yeap; David Harrington; M M Klatt; Geraldine S Pinkus; Maxine Jochelson; D S Rosenthal; Arthur T Skarin; George P Canellos
The m-BACOD combination chemotherapy regimen in large-cell lymphoma: analysis of the completed trial and comparison with the M-BACOD regimen.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(1):84-93.
1989: Luciano D'Adamio; Margaret A Shipp; E L Masteller; Ellis L Reinherz
Organization of the gene encoding common acute lymphoblastic leukemia antigen (neutral endopeptidase 24.11): multiple miniexons and separate 5' untranslated regions.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(18):7103-7.
1989: Margaret A Shipp; M M Klatt; B Yeap; Maxine Jochelson; Peter M Mauch; D S Rosenthal; Arthur T Skarin; George P Canellos
Patterns of relapse in large-cell lymphoma patients with bulk disease: implications for the use of adjuvant radiation therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(5):613-8.
1989: Margaret A Shipp; J Vijayaraghavan; E V Schmidt; E L Masteller; Luciano D'Adamio; Louis B Hersh; Ellis L Reinherz
Common acute lymphoblastic leukemia antigen (CALLA) is active neutral endopeptidase 24.11 ("enkephalinase"): direct evidence by cDNA transfection analysis.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(1):297-301.
1989: Peter Barker; Margaret A Shipp; Luciano D'Adamio; E L Masteller; Ellis L Reinherz
The common acute lymphoblastic leukemia antigen gene maps to chromosomal region 3 (q21-q27).
Journal of immunology (Baltimore, Md. : 1950) 1989;142(1):283-7.
1988: T J Ernst; A Gazdar; Jerome Ritz; Margaret A Shipp
Identification of a second transforming gene, rasn, in a human multiple myeloma line with a rearranged c-myc allele.
Blood 1988;72(4):1163-7.
1988: Margaret A Shipp; N E Richardson; P H Sayre; N R Brown; E L Masteller; Linda K Clayton; Jerome Ritz; Ellis L Reinherz
Molecular cloning of the common acute lymphoblastic leukemia antigen (CALLA) identifies a type II integral membrane protein.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(13):4819-23.
1988: R Tantravahi; Margaret A Shipp; T A Greeley; K Pavelka; M M Bern; D S Rosenthal; E Frei
Four patients with myelodysplastic syndrome with translocation (1;7)(p11;p11) including one patient with independent clones del(7)q22) [corrected] and t(1;7)(q21;q11)
Cancer genetics and cytogenetics 1988;30(1):83-90.
1987: Margaret A Shipp; Ellis L Reinherz
Differential expression of nuclear proto-oncogenes in T cells triggered with mitogenic and nonmitogenic T3 and T11 activation signals.
Journal of immunology (Baltimore, Md. : 1950) 1987;139(7):2143-8.
1987: George P Canellos; Arthur T Skarin; M M Klatt; D S Rosenthal; D C Case; Geraldine S Pinkus; Maxine Jochelson; B Y Yeap; Margaret A Shipp
The m-BACOD combination chemotherapy regimen in the treatment of diffuse large cell lymphoma.
Seminars in hematology 1987;24(2 Suppl 1):2-7.
1986: Margaret A Shipp; D P Harrington; M M Klatt; Maxine Jochelson; Geraldine S Pinkus; J L Marshall; D S Rosenthal; Arthur T Skarin; George P Canellos
Identification of major prognostic subgroups of patients with large-cell lymphoma treated with m-BACOD or M-BACOD.
Annals of internal medicine 1986;104(6):757-65.
1986: Margaret A Shipp; P Ahmed; C C Kannapell; J C Ford; D McCourt; J F Leykam; M Zacheis; C Bono; J M Davie; E Mustain
A new polymorphic determinant on HLA-DQ molecules.
Human immunology 1986;16(1):24-37.
1984: Margaret A Shipp; R C Takvorian; George P Canellos
High-dose cytosine arabinoside. Active agent in treatment of non-Hodgkin's lymphoma.
The American journal of medicine 1984;77(5):845-50.
1983: Margaret A Shipp; B D Schwartz; C C Kannapell; R C Griffith; M G Scott; P Ahmed; J M Davie; M H Nahm
A unique DR-related B cell differentiation antigen.
Journal of immunology (Baltimore, Md. : 1950) 1983;131(5):2458-67.